Epithelial ovarian cancer
Epithelial ovarian cancer generally presents at an advanced stage and is the most common
cause of gynaecological cancer death. Treatment requires expert multidisciplinary care …
cause of gynaecological cancer death. Treatment requires expert multidisciplinary care …
Epithelial ovarian cancer: evolution of management in the era of precision medicine
S Lheureux, M Braunstein… - CA: a cancer journal for …, 2019 - Wiley Online Library
Ovarian cancer is the second most common cause of gynecologic cancer death in women
around the world. The outcomes are complicated, because the disease is often diagnosed …
around the world. The outcomes are complicated, because the disease is often diagnosed …
[HTML][HTML] ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours …
The development of guidelines recommendations is one of the core activities of the
European Society for Medical Oncology (ESMO) and European Society of Gynaecologial …
European Society for Medical Oncology (ESMO) and European Society of Gynaecologial …
[HTML][HTML] Randomized trial of cytoreductive surgery for relapsed ovarian cancer
Background Treatment for patients with recurrent ovarian cancer has been mainly based on
systemic therapy. The role of secondary cytoreductive surgery is unclear. Methods We …
systemic therapy. The role of secondary cytoreductive surgery is unclear. Methods We …
Ovarian cancer, version 2.2020, NCCN clinical practice guidelines in oncology
DK Armstrong, RD Alvarez, JN Bakkum-Gamez… - Journal of the National …, 2021 - jnccn.org
Epithelial ovarian cancer is the leading cause of death from gynecologic cancer in the
United States and is the country's fifth most common cause of cancer mortality in women. A …
United States and is the country's fifth most common cause of cancer mortality in women. A …
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
Background The international standard of care for women with suspected advanced ovarian
cancer is surgical debulking followed by platinum-based chemotherapy. We aimed to …
cancer is surgical debulking followed by platinum-based chemotherapy. We aimed to …
CA125 and ovarian cancer: a comprehensive review
Simple Summary CA125 has been the most promising biomarker for screening ovarian
cancer; however, it still does not have an acceptable accuracy in population-based …
cancer; however, it still does not have an acceptable accuracy in population-based …
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
High-grade serous ovarian cancer (HGSOC) accounts for 70–80% of ovarian cancer deaths,
and overall survival has not changed significantly for several decades. In this Opinion article …
and overall survival has not changed significantly for several decades. In this Opinion article …
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer
I Vergote, CG Tropé, F Amant… - … England Journal of …, 2010 - Mass Medical Soc
Background Primary debulking surgery before initiation of chemotherapy has been the
standard of care for patients with advanced ovarian cancer. Methods We randomly assigned …
standard of care for patients with advanced ovarian cancer. Methods We randomly assigned …
Ovarian cancer
Epithelial ovarian cancer is the commonest cause of gynaecological cancer-associated
death. The disease typically presents in postmenopausal women, with a few months of …
death. The disease typically presents in postmenopausal women, with a few months of …